Talis Biomedical Corp
NASDAQ:TLIS
| Market Cap (Intraday) | 45.55M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.89 |
| 50-Day MA | $1.03 |
| 200-Day MA | $3.19 |
Talis Biomedical Corp Stock, NASDAQ:TLIS
230 Constitution Drive, Menlo Park, California 94025
United States of America
Phone: +1.650.433.3000
Number of Employees: 262
Description
Talis Biomedical Corp. develops and commercialize innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company was founded on June 26, 2013 and is headquartered in Menlo Park, CA.